SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A Betaville alert and elevated options activity have reignited speculation about a Viking partnership or buyout, with Novo and other large drugmakers frequently floated as potential partners. The deal talk is unconfirmed and debated as rumor-driven trading; traders also point to VK2735s obesity-drug pipeline and ObesityWeek presentations as context.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

A quarterly sales beat and raised outlook, driven by demand for oral Wegovy, are fueling renewed interest in Novo Nordisk. Bulls see the pill rollout as evidence of a growth recovery, while skeptics point to Lilly competition, pricing pressure and weakness in diabetes as unresolved risks.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure as CEO, amid reports of personal-conduct and China-related security scrutiny, has put Nvidias leadership succession at the center of discussion. Traders are divided between speculation that Huang could return or a successor could steady the company and concerns that leadership uncertainty and export-control scrutiny could weigh on the stock; others see the pullback as a buying opportunity ahead of earnings.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos earnings beat and raised full-year outlook have been overshadowed by concerns about lower gross margins from its hardware-heavy AI mix, slower product-order growth, and a softer sequential revenue outlook. Traders are split between viewing the selloff as an overreaction to strong results and questioning whether growth and margins can hold up.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra shares are under pressure after the European medicines committee reaffirmed its negative opinion on MIPLYFFA (arimoclomol) for Niemann-Pick disease type C, with a final European Commission decision still pending. Traders debate whether the setback was already expected and overplayed, pointing to U.S. sales and cash, while others criticize management and worry about the lost European opportunity.

Newsmax Inc. is a holding company, which engages in television broadcasting and multi-platform content publishing that produces original news and editorial content for consumers through various media outlets, including TV new channels, digital and print publications. It operates through the Broadcasting and Digital Segments. The Broadcasting segment produces and licenses news, business news and lifestyle content for distribution through both MVPDs and free OTT streaming platforms. The Digital segment is composed of Newsmax.com and affiliated websites. The company was founded by Christopher Ruddy in 1998 and is headquartered in Boca Raton, FL.

Newsmax Inc. - Ordinary Shares - Class B

Newsmax Inc

Newsmaxs stronger-than-expected Q3 results and higher FY26 sales guidance are driving attention, with traders cheering the improving profitability and growth outlook. Bulls are also speculating about a short squeeze, while others remain skeptical and warn that the stocks sharp moves may be volatile.

Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of brand names, including Nature’s Own, Dave’s Killer Bread, Wonder, Canyon Bakehouse, Tastykake, and Mrs. Freshley’s. The company was founded by William Howard Flowers, Sr. and Joseph Hampton Flowers, Jr. in 1919 and is headquartered in Thomasville, GA.

Flowers Foods, Inc.

Weak results and lowered guidance amid persistent volume declines and margin pressure are driving bearish attention, with traders also debating debt and dividend sustainability. Some see the selloff as an overshoot and point to heavy short interest as a possible setup for a rebound, while others expect continued weakness.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity is drawing attention after reports of preliminary takeover discussions involving Silver Lake and Saudi Arabias PIF, alongside a strong third-quarter report that included first-time GAAP profitability and rapid growth in its Vector advertising business. Traders are debating whether a potential offer would undervalue the company; no deal has been confirmed, and some remain focused on the earnings-driven growth story instead.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp pullback after a rapid speculative rally dominates discussion, with traders attributing it to profit-taking and a broader semiconductor/AI trade unwind amid Nvidia-related uncertainty. Some see the decline as a healthy reset and still expect AMD to benefit from Nvidias troubles, while others question the AI trades durability and AMDs valuation.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

MOD surged on reports that Samsung is discussing an acquisition, though neither a deal nor terms have been confirmed. Traders are debating whether a takeover would justify further upside or whether the reported valuation could leave the stock vulnerable to a pullback, against the backdrop of demand for AI data-center cooling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PGEN $INO Actually, mid-dosing surgical debulking is not included on the Voceryq label.

Per the FDA Prescribing Information, Voceryq only requires surgical debulking prior to Dose 1 to establish minimal residual disease—no additional surgeries are part of the 9-week regimen.

Mid-dosing removal of visible papillomas (prior to Doses 3 and 4) is specifically part of the Papzimeos label, not Voceryq’s. While surgeons may choose to do cleanups in real-world practice at their own discretion, it isn&#39;t part of Voceryq&#39;s FDA-approved instructions.

Bartholomew Kuma

Dany Italy

Wall Street Bull

Luis Barajas

Ben Roth

$PGEN $INO  The argument is both tired and insane. Inovians believe that achieving minimal residual disease mid dosing is improving Papzimeos outcomes and then believe that the 150-200 surgeons in the U.S. who will be treating the supermajority of RRP patients will not do the same when using Voceryq?! The FDA is well aware of this and it is included on the Voceryq label for this reason. The only thing saving INO right now is that it will take many quarters to prove out how stupid this proclamation will look a year+ from now.

StockTwits Web

Precigen Inc

Inovio Pharmaceuticals Inc

Jack Frost

StockTwits For Android 

 Actually, mid-dosing surgical debulking is not included on the Voceryq label.

Per the FDA Prescribing Information, Voceryq only requires surgical debulking prior to Dose 1 to establish minimal residual disease—no additional surgeries are part of the 9-week regimen.

Mid-dosing removal of visible papillomas (prior to Doses 3 and 4) is specifically part of the Papzimeos label, not Voceryq’s. While surgeons may choose to do cleanups in real-world practice at their own discretion, it isn't part of Voceryq's FDA-approved instructions.

@Lookingdown The few surgeons utilizing Voceryq are going to do cleanups in real-world practice at their own discretion.

 The few surgeons utilizing Voceryq are going to do cleanups in real-world practice at their own discretion.

@Lookingdown @JackFrost25 Both parties did surgeries before any dosing or treatment started. Let’s say some did require surgery during dosing window, it for sure counted against VoceryQ, but it didn’t count against $PGEN . 

Imagine if they did count against $PGEN end point. Your treatment would be trash. 🗑️ 

Facts.

StockTwits for iOS

 Both parties did surgeries before any dosing or treatment started. Let’s say some did require surgery during dosing window, it for sure counted against VoceryQ, but it didn’t count against 

 end point. Your treatment would be trash. 🗑️ 

Facts.